Thomas Hutson

Safety and Efficacy of Nivolumab in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study

Nicholas J. Vogelzang, Mark R. Olsen, Joshua J. McFarlane et al. · Clinical Genitourinary Cancer · 2020 · 106 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Subgroup analyses of METEOR, a randomized phase 3 trial of cabozantinib versus everolimus in patients (pts) with advanced renal cell carcinoma (RCC).

Bernard Escudier, Robert J. Motzer, Thomas Powles et al. · Journal of Clinical Oncology · 2016 · 15 citations

Medicine, Oncology, Pharmacology +17

Avelumab First-Line Maintenance for Locally Advanced or Metastatic Urothelial Carcinoma: Results From the Real-World US PATRIOT-II Study

Petros Grivas, Helen Moon, Shilpa Gupta et al. · Clinical Genitourinary Cancer · 2024 · 14 citations · Full text

Medicine, Oncology, Urology +14

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Andreas Lundqvist, Vincent van Hoef, Xiaonan Zhang et al. · Journal for ImmunoTherapy of Cancer · 2016 · 11 citations · Full text

Life Sciences, Immunology, Oncology +13